Earnings Flash > 新日本製薬 reports substantial 37.3% increase in net profit for the fiscal year ending September 2026 (Wealth Advisor)

The story

新日本製薬 released its consolidated results, reporting net sales of ¥43.455 billion (year-on-year comparison as stated in the article). Net profit, meanwhile, rose 37.3% from the previous fiscal year, marking a substantial increase.

The results were announced after the market close on 11 November.

At a glance

Company新日本製薬

Fiscal yearFiscal year ending September 2026 (consolidated)

Net sales¥43.455 billion

ProfitNet profit up 37.3%, marking a substantial increase

Date and timeAnnounced after the market close on 11 November

Reference information. Every claim resolves to something the story actually named.

Where this came from

We read each source in full and checked they agree on the core claim.

1/ 1 agree

All of them report the same thing.

finance.yahoo.co.jpNews

PrimaryOpen

Read the original articleGo to the source page

Reference information generated from public sources. It does not solicit or advise on investments. Prices are 15-minute delayed.